Drug Type Monoclonal antibody |
Synonyms PT-627 |
Target |
Mechanism PD-1 agonists(Programmed cell death protein 1 agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | US | 06 Aug 2020 |